Karrow Niel A, Leuschner Spencer E, Shandilya Umesh K, Mallard Bonnie A, Wagter-Lesperance Lauraine, Bridle Byram W
Department of Animal Biosciences, University of Guelph, Guelph, ON N1G 2W1, Canada.
Immunoceutica Inc., Cambridge, ON N1T 1N6, Canada.
Nutrients. 2025 Aug 19;17(16):2673. doi: 10.3390/nu17162673.
Vitamin D (VD) plays a critical role in human health, with deficiencies linked to a range of adverse outcomes, including compromised immune function and increased disease risk. While environmental factors such as sunlight exposure and diet influence circulating VD levels, genetic variation is a significant and underappreciated contributor to interindividual differences in serum 25-hydroxyvitamin D [25(OH)D] concentrations. This review provides a comprehensive summary of genetic variants in key genes involved in VD synthesis (e.g., , , ), transport (), and metabolism (, ), as well as in cholesterol transport proteins (, , ). We examine how single-nucleotide polymorphisms (SNPs) and rare mutations in these genes affect enzyme activity, VD bioavailability, and overall 25(OH)D status. Importantly, we highlight evidence supporting gene-by-environment interactions and population-specific allele frequencies that further shape individual VD responses. In the context of clinical nutrition and precision health, these findings support the development of genomic risk scores (GRSs) to identify individuals at risk for deficiency or toxicity and guide personalized VD supplementation strategies. Regular monitoring of serum 25(OH)D alongside genetic screening may improve clinical outcomes by helping to achieve optimal VD immunosufficiency while minimizing the risk of adverse effects.
维生素D(VD)在人类健康中起着关键作用,其缺乏与一系列不良后果相关,包括免疫功能受损和疾病风险增加。虽然阳光照射和饮食等环境因素会影响循环中的VD水平,但基因变异是血清25-羟基维生素D [25(OH)D] 浓度个体差异的一个重要且未得到充分认识的因素。本综述全面总结了参与VD合成(如 、 、 )、转运( )和代谢( 、 )的关键基因以及胆固醇转运蛋白( 、 、 )中的基因变异。我们研究了这些基因中的单核苷酸多态性(SNP)和罕见突变如何影响酶活性、VD生物利用度以及总体25(OH)D状态。重要的是,我们强调了支持基因与环境相互作用以及特定人群等位基因频率的证据,这些进一步塑造了个体对VD的反应。在临床营养和精准健康的背景下,这些发现支持开发基因组风险评分(GRS)以识别有缺乏或中毒风险的个体,并指导个性化的VD补充策略。定期监测血清25(OH)D并结合基因筛查,通过帮助实现最佳的VD免疫充足状态同时最小化不良反应风险,可能会改善临床结果。